Document is current
Any future updates will be listed below
-
Authors
Choi, Julie
Strickland, Amy
Loo, Hui Qi
Dong, Wendy
Barbar, Lilianne
Bloom, A. Joseph
Sasaki, Yo
Jin, Sheng Chih
DiAntonio, Aaron
Milbrandt, Jeffrey
-
Funding
Funding for this research was provided by:
National Human Genome Research Institute (HG000045)
National Institutes of Health (NS133348, NS133348)
- License Information
-
More Information
Article History
Received: 24 February 2025
Accepted: 1 May 2025
First Online: 23 May 2025
Declarations
:
: JM and AD are co-founders, scientific advisory board members, and shareholders of Disarm Therapeutics, a wholly owned subsidiary of Eli Lilly and scientific advisory board members of Asha Therapeutics. The authors have no other competing conflicts or financial interests.
